BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16955630)

  • 1. Evaluation of a microparticle enzyme immunoassay for the measurement of sirolimus in whole blood (Abbott IMx sirolimus).
    Scholer A; Von Rickenbach R; Faffa G; Vetter B
    Clin Lab; 2006; 52(7-8):325-34. PubMed ID: 16955630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a new immunoassay to measure sirolimus blood concentrations compared to a tandem mass-spectrometric chromatographic analysis.
    Fillée C; Mourad M; Squifflet JP; Malaise J; Lerut J; Reding R; Borghgraef P; Vanbinst R; Wallemacq PE
    Transplant Proc; 2005; 37(6):2890-1. PubMed ID: 16182845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the reintroduced MEIA assay with HPLC-MS/MS for the determination of whole-blood sirolimus from transplant recipients.
    Morris RG; Salm P; Taylor PJ; Wicks FA; Theodossi A
    Ther Drug Monit; 2006 Apr; 28(2):164-8. PubMed ID: 16628125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the CEDIA and MEIA assays for the measurement of sirolimus in organ transplant recipients.
    Colantonio DA; Borden KK; Clarke W
    Clin Biochem; 2007 Jun; 40(9-10):680-7. PubMed ID: 17428457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of everolimus in whole blood using the Abbott IMx sirolimus microparticle enzyme immunoassay.
    Bouzas L; Tutor JC
    Clin Biochem; 2007 Jan; 40(1-2):132-6. PubMed ID: 17011541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-center evaluation of analytical performance of the microparticle enzyme immunoassay for sirolimus.
    Wilson D; Johnston F; Holt D; Moreton M; Engelmayer J; Gaulier JM; Luthe H; Marquet P; Moscato D; Oellerich M; Mosso R; Streit F; Brunet M; Fillee C; Schmid R; Wallemacq P; Barnes G
    Clin Biochem; 2006 Apr; 39(4):378-86. PubMed ID: 16545357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of an immunoassay (Abbott-IMX Analyzer) allowing routine determination of sirolimus: comparison with LC-MS method.
    Bargnoux AS; Bonardet A; Chong G; Garrigue V; Deleuze S; Dupuy AM; Mourad G; Cristol JP
    Transplant Proc; 2006 Sep; 38(7):2352-3. PubMed ID: 16980087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the Abbott IMx sirolimus assay in relation to a high-performance liquid chromatography-ultraviolet method.
    Johnson RN; Sargon R; Woollard G; Davidson J
    Ann Clin Biochem; 2005 Sep; 42(Pt 5):394-7. PubMed ID: 16168196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
    Westley IS; Taylor PJ; Salm P; Morris RG
    Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoassay determination of rapamycin: reliability of the method with respect to liquid chromatography mass spectrometric quantification.
    Pieri M; Capone D; Gentile A; Miraglia N; Leo E; Federico S; Basile V; Acampora A
    Clin Transplant; 2007; 21(5):633-7. PubMed ID: 17845638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-performance liquid chromatography versus immunoassay for the measurement of sirolimus: comparison of two methods.
    Zochowska D; Bartłomiejczyk I; Kamińska A; Senatorski G; Paczek L
    Transplant Proc; 2006; 38(1):78-80. PubMed ID: 16504669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the CEDIA and MEIA assays for measurement of tacrolimus in organ transplant recipients.
    Liang SL; Breaud A; Dunn W; Clarke W
    Clin Chim Acta; 2008 Oct; 396(1-2):1-6. PubMed ID: 18606158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Abbott ARCHITECT i2000 sirolimus assay and comparison with the Abbott IMx sirolimus assay and an established liquid chromatography-tandem mass spectrometry method.
    Johnson-Davis KL; De S; Jimenez E; McMillin GA; De BK
    Ther Drug Monit; 2011 Aug; 33(4):453-9. PubMed ID: 21743377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-site analytical evaluation of a chemiluminescent magnetic microparticle immunoassay (CMIA) for sirolimus on the Abbott ARCHITECT analyzer.
    Schmid RW; Lotz J; Schweigert R; Lackner K; Aimo G; Friese J; Rosiere T; Dickson D; Kenney D; Maine GT
    Clin Biochem; 2009 Oct; 42(15):1543-8. PubMed ID: 19563794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term evaluation of analytical methods used in sirolimus therapeutic drug monitoring.
    Holt DW; Mandelbrot DA; Tortorici MA; Korth-Bradley JM; Sierka D; Levy DI; See Tai S; Horowitz GL
    Clin Transplant; 2014 Feb; 28(2):243-51. PubMed ID: 24476346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of blood sirolimus concentrations in liver and kidney transplant recipients using the Innofluor fluorescence polarization immunoassay: comparison with the microparticle enzyme immunoassay and high-performance liquid chromatography-ultraviolet method.
    Bouzas L; Hermida J; Tutor JC
    Ups J Med Sci; 2009; 114(1):55-61. PubMed ID: 19242874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic monitoring of tacrolimus concentrations in blood of renal and liver transplant recipients: comparison of microparticle enzyme immunoassay and enzyme multiplied immunoassay methods.
    Bartlomiejczyk I; Zochowska D; Sanko-Resmer J; Matuszewicz D; Paczek L
    Transplant Proc; 2006; 38(1):94-6. PubMed ID: 16504673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytical performance characteristics of the Abbott Architect i2000 Tacrolimus assay; comparisons with liquid chromatography-tandem mass spectrometry (LC-MS/MS) and Abbott IMx methods.
    De BK; Jimenez E; De S; Sawyer JC; McMillin GA
    Clin Chim Acta; 2009 Dec; 410(1-2):25-30. PubMed ID: 19751714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods.
    Akbas SH; Ozdem S; Caglar S; Tuncer M; Gurkan A; Yucetin L; Senol Y; Demirbas A; Gultekin M; Ersoy FF; Akaydin M
    Clin Biochem; 2005 Jun; 38(6):552-7. PubMed ID: 15885236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunoassay for the measurement of sirolimus.
    Jones K; Saadat-Lajevard S; Lee T; Horwatt R; Hicks D; Johnston A; Holt DW
    Clin Ther; 2000; 22 Suppl B():B49-61. PubMed ID: 10823373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.